Experiments inhibiting M3R activity in HT-29 cells [46] or comparing M3R expression in CRC to normal colon tissue [44] confirmed the impact of M3R/CHRM3 expression and activity on CRC progression. The gene discussed is CHRM3; the disease is colorectal carcinoma.